Leerink Partners下调Centessa评级至“与市场持平” 目标价上调至40美元

美股速递
Apr 01

投资机构Leerink Partners宣布将Centessa Pharmaceuticals plc(CNTA)的股票评级从“跑赢大盘”下调至“与市场持平”,同时将其目标股价从36美元上调至40美元。此次调整反映了该机构对Centessa未来估值潜力的重新评估。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10